Gabriela Rusu-Zota1, Alexandra Burlui2, Elena Rezus2, Luminita Paduraru3, Victorita Sorodoc4. 1. Department of Pharmacology-Algesiology, Faculty of Medicine, University of Medicine and Pharmacy 'Grigore T. Popa', Universitatii St. no. 16, 700115 Iasi, Romania. 2. Department of Rheumatology and Physiotherapy, Faculty of Medicine, University of Medicine and Pharmacy 'Grigore T. Popa', Universitatii St. no. 16, 700115 Iasi, Romania. 3. Department of Mother and Child Care (Neonatology), Faculty of Medicine, University of Medicine and Pharmacy 'Grigore T. Popa', Universitatii St. no. 16, 700115 Iasi, Romania. 4. Department of Internal Medicine (Toxicology), Faculty of Medicine, University of Medicine and Pharmacy 'Grigore T. Popa', Universitatii St. no. 16, 700115 Iasi, Romania.
Abstract
Background and objectives: The connections between the imidazoline system and multiple other neurotransmitter systems in the brain (adrenergic, dopaminergic, serotoninergic, glutamatergic, opioid) indicate the complexity of the mechanisms underlying motor activity and behavior. The aim of the present research was to investigate the effects of the combination of ephedrine (EPD) and imidazoline antagonists idazoxan (IDZ) and efaroxan (EFR) on the endurance performance in the treadmill test in rats. Materials and Methods: We used Wistar rats distributed as follows: Group 1 (Control) receiving distilled water 0.3 mL/100 g body weight; Group 2 (EPD) receiving 20 mg/kg ephedrine; Group 3 (EPD + IDZ) receiving 20 mg/kg ephedrine + 3 mg/kg idazoxan; Group 4 (EPD + EFR) receiving 20 mg/kg ephedrine + 1 mg/kg efaroxan. An additional group (C) of animals receiving 0.3 mL/100 g body weight distilled water (but not subjected) to effort was used. Endurance capacity was evaluated using a treadmill running PanLAB assay. The evaluation of the substances' influence on oxidative stress was performed by spectrophotometric determination of superoxide dismutase (SOD) and glutathione peroxidase (GPX) activity. Results: Treatment with EPD-IDZ and EPD-EFR were correlated with a longer distance traveled on the belt and with a decrease in the necessary electric shocks to motivate the animal to continue running in the forced locomotion test. Additionally, an increase in the activity of antioxidant enzymes was found. Conclusions: Idazoxan and efaroxan potentiated the physical effort-related effects of ephedrine with regard to endurance capacity and antioxidant activity in rats.
Background and objectives: The connections between the imidazoline system and multiple other neurotransmitter systems in the brain (adrenergic, dopaminergic, serotoninergic, glutamatergic, opioid) indicate the complexity of the mechanisms underlying motor activity and behavior. The aim of the present research was to investigate the effects of the combination of ephedrine (EPD) and imidazoline antagonists idazoxan (IDZ) and efaroxan (EFR) on the endurance performance in the treadmill test in rats. Materials and Methods: We used Wistar rats distributed as follows: Group 1 (Control) receiving distilled water 0.3 mL/100 g body weight; Group 2 (EPD) receiving 20 mg/kg ephedrine; Group 3 (EPD + IDZ) receiving 20 mg/kg ephedrine + 3 mg/kg idazoxan; Group 4 (EPD + EFR) receiving 20 mg/kg ephedrine + 1 mg/kg efaroxan. An additional group (C) of animals receiving 0.3 mL/100 g body weight distilled water (but not subjected) to effort was used. Endurance capacity was evaluated using a treadmill running PanLAB assay. The evaluation of the substances' influence on oxidative stress was performed by spectrophotometric determination of superoxide dismutase (SOD) and glutathione peroxidase (GPX) activity. Results: Treatment with EPD-IDZ and EPD-EFR were correlated with a longer distance traveled on the belt and with a decrease in the necessary electric shocks to motivate the animal to continue running in the forced locomotion test. Additionally, an increase in the activity of antioxidant enzymes was found. Conclusions: Idazoxan and efaroxan potentiated the physical effort-related effects of ephedrine with regard to endurance capacity and antioxidant activity in rats.
Authors: Madhura P Dixit; Prajwal P Thakre; Akshay S Pannase; Manish M Aglawe; Brijesh G Taksande; Nandkishor R Kotagale Journal: Eur J Pharmacol Date: 2014-03-19 Impact factor: 4.432
Authors: Bruno Lima Giacobbo; Janine Doorduin; Hans C Klein; Rudi A J O Dierckx; Elke Bromberg; Erik F J de Vries Journal: Mol Neurobiol Date: 2018-08-17 Impact factor: 5.590
Authors: Israel Pérez-Torres; Linaloe Manzano-Pech; María Esther Rubio-Ruíz; María Elena Soto; Verónica Guarner-Lans Journal: Molecules Date: 2020-05-31 Impact factor: 4.411